| scholarly article | Q13442814 |
| P2093 | author name string | G J Hämmerling | |
| Y C Kong | |||
| C S David | |||
| G Strauss | |||
| A A Giraldo | |||
| L C Lomo | |||
| R W Motte | |||
| J Baisch | |||
| P2860 | cites work | Mice lacking MHC class II molecules | Q28588991 |
| The association of goitrous autoimmune thyroiditis with HLA-DR5. | Q34273805 | ||
| HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis | Q36366088 | ||
| Hashimoto's thyroiditis is associated with HLA-DRw3. | Q39494526 | ||
| Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes | Q39666127 | ||
| Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens | Q42801460 | ||
| Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody | Q43913093 | ||
| Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells. | Q44217579 | ||
| Suppression in experimental autoimmune thyroiditis: The role of unique and shared determinants on mouse thyroglobulin in self-tolerance | Q44279577 | ||
| Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families | Q44974887 | ||
| Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice | Q46116159 | ||
| Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. | Q50703170 | ||
| Characterization of the in vitro murine T-cell proliferative responses to murine and human thyroglobulins in thyroiditis-susceptible and -resistant mice. | Q54446671 | ||
| HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis | Q67521430 | ||
| Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles | Q68034034 | ||
| HLA Associations with Hashimoto's thyroiditis | Q68305891 | ||
| Goitrous Hashimoto's thyroiditis. Lack of association with HLA antigens | Q68732111 | ||
| Association of goitrous autoimmune thyroiditis with HLA-DR3 in eastern Hungary | Q68834789 | ||
| Characterization of cell lines expressing mutant I-Ab and I-Ak molecules allows the definition of distinct serologic epitopes on A alpha and A beta polypeptides | Q68958180 | ||
| Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex | Q70654490 | ||
| HLA-D in Hashimoto's thyroiditis | Q70986140 | ||
| Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination | Q71586961 | ||
| Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouse H-2 | Q71601538 | ||
| HLA-DR and Hashimoto's thyroiditis | Q71997711 | ||
| Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice | Q72049883 | ||
| HLA-DR epitope region definition by use of monoclonal antibody probes | Q72620786 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune thyroiditis | Q187842 |
| P304 | page(s) | 1167-1172 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene | |
| P478 | volume | 184 |
| Q30278514 | A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus |
| Q34912369 | A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice |
| Q52927126 | A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. |
| Q35694206 | A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. |
| Q73208381 | Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis |
| Q40054259 | An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice |
| Q37388149 | Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. |
| Q26852013 | Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity |
| Q79253306 | Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes |
| Q80398673 | Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice |
| Q79780581 | Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice |
| Q44639182 | Development of a Murine Model of Autoimmune Thyroiditis Induced with Homologous Mouse Thyroid Peroxidase |
| Q37149410 | Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis |
| Q35214407 | Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis. |
| Q37404065 | Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice. |
| Q73732580 | Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M |
| Q37381153 | Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis |
| Q47107151 | Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes |
| Q36028231 | Genetic aspects of immune-mediated adverse drug effects |
| Q79369718 | Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA |
| Q36954791 | H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis |
| Q35605716 | HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease |
| Q39522118 | HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice |
| Q33713285 | HLA class II transgenic mice as models of human diseases |
| Q37172531 | HLA class II transgenic mice mimic human inflammatory diseases. |
| Q39799339 | HLA transgenic mice as humanized mouse models of disease and immunity. |
| Q74209577 | HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible |
| Q30424263 | HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD |
| Q37307584 | Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity |
| Q37257526 | Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis |
| Q33554688 | Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice |
| Q33840539 | Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice |
| Q35411077 | Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice |
| Q35878274 | Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis |
| Q30353698 | Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice |
| Q24555739 | Immunogenetics of Hashimoto's thyroiditis |
| Q46692301 | In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II. |
| Q51581750 | Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model. |
| Q36973929 | Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. |
| Q35620743 | Mice lacking all conventional MHC class II genes |
| Q34112889 | New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models |
| Q98281015 | Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling |
| Q33658400 | Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 |
| Q37274049 | Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation |
| Q33723303 | Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice. |
| Q34112884 | Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis |
| Q37360659 | Peptides presented in vivo by HLA-DR in thyroid autoimmunity. |
| Q89840255 | Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors |
| Q42061110 | Production of CD4⁺ and CD8⁺ T cell hybridomas |
| Q40094147 | Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. |
| Q33770310 | Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries |
| Q80473545 | Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice |
| Q47826796 | Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis. |
| Q40706013 | Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis |
| Q37084243 | The "A, B and C" of Her-2 DNA vaccine development |
| Q37051756 | The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology |
| Q35605705 | The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases |
| Q28068607 | Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease |
| Q44651431 | Thyrotropin Receptor-DNA Vaccination of Transgenic Mice Expressing HLA-DR3 or HLA-DQ6b |
| Q37323685 | Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity |
| Q35147486 | Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells |
| Q35089019 | VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone |
| Q83130328 | WITHDRAWN: A brief autobiography |
| Q44916977 | Weak or absent evidence for the association of HLA-DR antigens with risk of thyroid carcinoma: a meta-analysis of observational studies |
| Q33895048 | cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity |
Search more.